key: cord-0050705-2dn7gita
authors: Andino, Juan J.; Ellimoottil, Chad
title: AUTHOR REPLY
date: 2020-09-26
journal: Urology
DOI: 10.1016/j.urology.2020.05.083
sha: 9b81faab1b96e6ecef0e7bb8b6f65e1832676666
doc_id: 50705
cord_uid: 2dn7gita

nan

socio-demographically and physically disadvantaged patients, who often pay a high price to physically come to clinic.

While COVID-19 will likely prove to serve as the tipping point for broad adoption of telemedicine, the work to be done is in getting these services to the appropriate patients with efficiency, quality and accessibility. Caution must be taken that in overcoming a barrier to access as it relates to geography, or travel time, we do not ignore barriers to access due to lack of devices, internet or language services. This will require rigorous implementation and delivery science to define strategies tailored to each unique and vulnerable population, including the elderly, non-English speakers, and those with lower socioeconomic status. Promise and perils abound. 

All patients in our study were previously established with and examined by a urologist. Over 80% had commercial insurance, resulting in reimbursement comparable to clinic encounters due to Michigan's favorable telehealth parity laws. 1,2 The regulatory landscape limited which patients could be seen from their homes and how clinics were reimbursed for video visits. It is possible that new patients who have never seen a urologist, the elderly, and those whose socioeconomic status qualify them for Medicaid stand to benefit the most from reduced travel time and the convenience of performing these visits from their home or work.

However, the policies that previously provided only sub-sets of our patients with the ability to use telehealth have all changed. COVID-19 resulted in unprecedented and rapid changes in the reimbursement and regulation of telehealth after the pandemic was declared a national emergency on March 17, 2020. 3 Since then, the disproportionate impact of COVID-19 on minority populations 4 in the United States has brought discussions about health disparities to the forefront of medical and public discourse. We find ourselves at a pivotal moment for thoughtfully designing the future of care delivery in the United States. Physicians must advocate to prevent a return to the status quo. For the coming years, we need to work within the COVID-19 reimbursement and regulatory environment to rigorously evaluate telehealth. How do new patient encounters impact access to specialty care? How do Medicare and Medicaid beneficiaries use telehealth to connect with their providers? Is the availability and use of telehealth affected by racial, ethnic, or cultural characteristics? Like much of medicine, there is no silver bullet that will meet the needs of our diverse populations. Rather we should leverage different forms of telehealth, from e-consults to telephone encounters and video visits, in order to bring specialty care to our patients. Rather than expecting them to show up at our doorsteps.

Projecting the urology workforce over the next 20 years

Development and implementation of expected practices to reduce inappropriate variations in clinical practice

State of the States Report: Coverage and Reimbursement

The impact of video visits on measures of clinical efficiency and reimbursement

Medicare Telemedicine Health Care Provider Fact Sheet

COVID-19 and racial/ethnic disparities